SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 4, 2026

DNLI

Denali Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $312K total
Actionable Insight • Neutral

The insider selling is too small in dollar terms to signal a bearish view. Monitor for any larger insider sales or changes in fundamentals (e.g., upcoming pipeline readouts or earnings) that could drive price action. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$22.08
T+0 close · Sep 4, 2026 · via day close
Latest settled
−12.68%
T+20 · $19.28 · next T+60 in 15d
Vs SPY
−14.40%
α at T+20
Latest observation
−5.88%
T+48 · FF3 residual α
  1. T+0 · Sep 8 $22.08entry
  2. T+1 · 2mo ago −2.31%α −1.84% · $21.57
  3. T+5 · 2mo ago −7.70%α −6.58% · $20.38
  4. T+20 · 6w ago −12.68%α −14.40% · $19.28
  5. T+49 · todayOpen
  6. T+60 · in 15d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Denali Therapeutics insiders (COFO/Secretary Schuth and Director Thornberry) sold a combined $312K in open-market transactions over a 2-day window. The total value represents only ~0.009% of the company's $3.6B market cap, a trivial amount that does not convey material negative information.

Key Financial Metrics

Direction
selling
Total Value
$312.0K
Insiders
2

Key Facts

  • Total insider sales: $312K across 2 insiders (Schuth $65K, Thornberry $247K)
  • Sales represent ~0.009% of DNLI's $3.6B market cap, well below the 0.1% materiality threshold
  • Both transactions were open-market sells; no 10b5-1 plan indicated
  • No insider purchases in the cluster to offset the selling

Financial Impact

Trivial, $312K in sales is immaterial relative to $3.6B market cap

Risk Factors

  • Insider selling could accelerate if management becomes more bearish on upcoming catalysts

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (26 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DNLI-1788555777764

Track record

17 reports on DNLI

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +23.19% at T+60 after the May 7, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.75 Now $18.08 −3.55% settles Nov 17
  2. Nov 3, 202613d ago 8-K Bullish 6/10 No price data
  3. Nov 3, 202613d ago Press Release Neutral 5/10 Entry $20.96 to $19.72 Now $18.08 −13.74% ▼ −5.92% −1.51% vs SPY
  4. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $18.94 to $18.86 Now $18.08 −4.54% ▼ −0.42% +0.06% vs SPY
  5. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $18.66 Now $18.08 −3.11% No price data
  6. Sep 9, 20269w ago Insider Cluster Neutral 2/10 Entry $21.40 to $21.09 Now $18.08 −15.51% ▼ −1.45% −2.30% vs SPY
  7. Sep 4, 202610w ago Insider Cluster Neutral 2/10 Viewing Entry $22.08 to $21.57 Now $18.08 −18.12% ▼ −2.31% −1.84% vs SPY
  8. Aug 6, 202614w ago 8-K Mixed 6/10 Entry $24.83 to $25.00 Now $18.08 −27.18% ▲ +0.68% +0.71% vs SPY
  9. Jul 27, 202616w ago Press Release Neutral 1/10 Entry $24.05 Now $18.08 −24.82% No price data
  10. Jun 18, 202621w ago 8-K Bullish 6/10 Entry $23.31 to $24.05 Now $18.08 −22.44% ▲ +3.17% +3.49% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (11h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 4, 2026